93 related articles for article (PubMed ID: 22577101)
1. Compensatory mutations in agrC partly restore fitness in vitro to peptide deformylase inhibitor-resistant Staphylococcus aureus.
Zorzet A; Andersen JM; Nilsson AI; Møller NF; Andersson DI
J Antimicrob Chemother; 2012 Aug; 67(8):1835-42. PubMed ID: 22577101
[TBL] [Abstract][Full Text] [Related]
2. Peptide deformylase in Staphylococcus aureus: resistance to inhibition is mediated by mutations in the formyltransferase gene.
Margolis PS; Hackbarth CJ; Young DC; Wang W; Chen D; Yuan Z; White R; Trias J
Antimicrob Agents Chemother; 2000 Jul; 44(7):1825-31. PubMed ID: 10858337
[TBL] [Abstract][Full Text] [Related]
3. Reduction of the fitness burden of quinolone resistance in Pseudomonas aeruginosa.
Kugelberg E; Löfmark S; Wretlind B; Andersson DI
J Antimicrob Chemother; 2005 Jan; 55(1):22-30. PubMed ID: 15574475
[TBL] [Abstract][Full Text] [Related]
4. Antistaphylococcal activity of LBM415, a new peptide deformylase inhibitor, compared with those of other agents.
Credito K; Lin G; Ednie LM; Appelbaum PC
Antimicrob Agents Chemother; 2004 Oct; 48(10):4033-6. PubMed ID: 15388473
[TBL] [Abstract][Full Text] [Related]
5. Analysis of mutational resistance to trimethoprim in Staphylococcus aureus by genetic and structural modelling techniques.
Vickers AA; Potter NJ; Fishwick CW; Chopra I; O'Neill AJ
J Antimicrob Chemother; 2009 Jun; 63(6):1112-7. PubMed ID: 19383727
[TBL] [Abstract][Full Text] [Related]
6. In vitro antibacterial activity of the peptide deformylase inhibitor BB-83698.
Lofland D; Difuntorum S; Waller A; Clements JM; Weaver MK; Karlowsky JA; Johnson K
J Antimicrob Chemother; 2004 Apr; 53(4):664-8. PubMed ID: 14973152
[TBL] [Abstract][Full Text] [Related]
7. Evolution of resistance mechanisms and biological characteristics of rifampicin-resistant Staphylococcus aureus strains selected in vitro.
Wang C; Fang R; Zhou B; Tian X; Zhang X; Zheng X; Zhang S; Dong G; Cao J; Zhou T
BMC Microbiol; 2019 Sep; 19(1):220. PubMed ID: 31533633
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms and physiological effects of protamine resistance in Salmonella enterica serovar Typhimurium LT2.
Pränting M; Andersson DI
J Antimicrob Chemother; 2010 May; 65(5):876-87. PubMed ID: 20233778
[TBL] [Abstract][Full Text] [Related]
9. Molecular surveillance of putative virulence factors and antibiotic resistance in Staphylococcus aureus isolates recovered from intra-mammary infections of river buffaloes.
Kumar R; Yadav BR; Anand SK; Singh RS
Microb Pathog; 2011; 51(1-2):31-8. PubMed ID: 21440053
[TBL] [Abstract][Full Text] [Related]
10. Staphylococcus aureus formyl-methionyl transferase mutants demonstrate reduced virulence factor production and pathogenicity.
Lewandowski T; Huang J; Fan F; Rogers S; Gentry D; Holland R; Demarsh P; Aubart K; Zalacain M
Antimicrob Agents Chemother; 2013 Jul; 57(7):2929-36. PubMed ID: 23571548
[TBL] [Abstract][Full Text] [Related]
11. Persistence of rRNA operon mutated copies and rapid re-emergence of linezolid resistance in Staphylococcus aureus.
Tsakris A; Pillai SK; Gold HS; Thauvin-Eliopoulos C; Venkataraman L; Wennersten C; Moellering RC; Eliopoulos GM
J Antimicrob Chemother; 2007 Sep; 60(3):649-51. PubMed ID: 17623697
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial activity of a novel peptide deformylase inhibitor, LBM415, tested against respiratory tract and cutaneous infection pathogens: a global surveillance report (2003-2004).
Watters AA; Jones RN; Leeds JA; Denys G; Sader HS; Fritsche TR
J Antimicrob Chemother; 2006 May; 57(5):914-23. PubMed ID: 16549511
[TBL] [Abstract][Full Text] [Related]
13. Restoring methicillin-resistant Staphylococcus aureus susceptibility to β-lactam antibiotics.
Tan CM; Therien AG; Lu J; Lee SH; Caron A; Gill CJ; Lebeau-Jacob C; Benton-Perdomo L; Monteiro JM; Pereira PM; Elsen NL; Wu J; Deschamps K; Petcu M; Wong S; Daigneault E; Kramer S; Liang L; Maxwell E; Claveau D; Vaillancourt J; Skorey K; Tam J; Wang H; Meredith TC; Sillaots S; Wang-Jarantow L; Ramtohul Y; Langlois E; Landry F; Reid JC; Parthasarathy G; Sharma S; Baryshnikova A; Lumb KJ; Pinho MG; Soisson SM; Roemer T
Sci Transl Med; 2012 Mar; 4(126):126ra35. PubMed ID: 22440737
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms and fitness costs of tigecycline resistance in Escherichia coli.
Linkevicius M; Sandegren L; Andersson DI
J Antimicrob Chemother; 2013 Dec; 68(12):2809-19. PubMed ID: 23843301
[TBL] [Abstract][Full Text] [Related]
15. Resistance of Streptococcus pneumoniae to deformylase inhibitors is due to mutations in defB.
Margolis P; Hackbarth C; Lopez S; Maniar M; Wang W; Yuan Z; White R; Trias J
Antimicrob Agents Chemother; 2001 Sep; 45(9):2432-5. PubMed ID: 11502510
[TBL] [Abstract][Full Text] [Related]
16. Staphylococcus aureus nasal carriage, virulence traits, antibiotic resistance mechanisms, and genetic lineages in healthy humans in Spain, with detection of CC398 and CC97 strains.
Lozano C; Gómez-Sanz E; Benito D; Aspiroz C; Zarazaga M; Torres C
Int J Med Microbiol; 2011 Aug; 301(6):500-5. PubMed ID: 21570348
[TBL] [Abstract][Full Text] [Related]
17. Detection of virulence genes in Staphylococcus aureus isolated from paper currency.
Kumar JD; Negi YK; Gaur A; Khanna D
Int J Infect Dis; 2009 Nov; 13(6):e450-5. PubMed ID: 19477670
[TBL] [Abstract][Full Text] [Related]
18. Target gene mutations among methicillin-resistant Staphylococcus aureus and methicillin-susceptible S. aureus with elevated MICs of enrofloxacin obtained from diseased food-producing animals or food of animal origin.
Hauschild T; Fessler AT; Billerbeck C; Wendlandt S; Kaspar H; Mankertz J; Schwarz S; Kadlec K
J Antimicrob Chemother; 2012 Jul; 67(7):1791-3. PubMed ID: 22457312
[No Abstract] [Full Text] [Related]
19. Role of hypermutability on bacterial fitness and emergence of resistance in experimental osteomyelitis due to Staphylococcus aureus.
Daurel C; Prunier AL; Chau F; Garry L; Leclercq R; Fantin B
FEMS Immunol Med Microbiol; 2007 Nov; 51(2):344-9. PubMed ID: 17714489
[TBL] [Abstract][Full Text] [Related]
20. Emergence and maintenance of resistance to fluoroquinolones and coumarins in Staphylococcus aureus: predictions from in vitro studies.
Vickers AA; O'Neill AJ; Chopra I
J Antimicrob Chemother; 2007 Aug; 60(2):269-73. PubMed ID: 17556355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
